Biotech

For Applied DNA, a lucrative new passage to India

By GREGORY ZELLER // Growing interest from Asian-Pacific textile manufacturers has prompted a Long Island biotech to establish a new testing laboratory in India. Stony Brook-based Applied DNA Sciences on Tuesday announced the opening of its new Central DNA Testing Laboratory in Ahmedabad, a city of 5.6 million residents in the Western India state of Gujarat, a manufacturing and distribution hub advancing cotton and other textiles, as well as fertilizers, petrochemicals and pharmaceuticals. From there,…

Read More

Codagenix scores again: $3M to hunt down deadly RSV

By GREGORY ZELLER // A fresh $3 million in public and private investments has set Codagenix Inc. on the trail of another nefarious disease. Already developing vaccines for Zika virus, the mutating menace Influenza A and a host of other viral villains, Codagenix will now focus its vaccine-creation might on Respiratory Syncytial Virus through a $1.5 million Phase II Small Business Innovation Research grant from the National Institutes of Health and another $1.5 million in…


In REDC love fest, CSHL kicks off $75M makeover

By GREGORY ZELLER // There was another major advance for biochemistry Thursday at Cold Spring Harbor Laboratory, but this one didn’t involve gas chromatographs or infrared spectrometers or a single test tube. Just a shovel. With Gov. Andrew Cuomo and a host of regional and state representatives on hand, the world-class scientific research facility officially broke ground on the renovation of its Demerec Laboratory, one of four CSHL laboratories being remade with a big assist…


NIH sees a need for speed in Traverse Biosciences

By GREGORY ZELLER // The National Institutes of Health has welcomed a rising Stony Brook biotech into its competitive Commercialization Accelerator Program. Traverse Biosciences, which is attempting to commercialize novel drug candidates for the treatment of inflammatory diseases affecting animals and humans, has landed one of 80 annual slots in the CAP, a nine-month program hosted by the NIH and the Larta Institute, a California-based networking group promoting international innovation. The NIH CAP – which…


Printing partnership takes Applied DNA global, again

By GREGORY ZELLER // Diversity-driven Stony Brook biotech Applied DNA Sciences has added yet another vertical market to its rapidly expanding collection: laser printers. And not just printers and inks but third parties that use them to tag their products, packaging and supply-chain components, all available through a new “strategic partnership” between Applied DNA and Videojet Technologies. Under the guidance of an all-star business-development team, the biotech – which specializes in can’t-be-copied, can’t-be-broken DNA-based security…


Feds back NYIT professors on RNA-sequencing quest

By GREGORY ZELLER // Diverse disciplines are coming together at NYIT, where a multi-year National Institutes of Health grant is fueling next-level RNA research – and, possibly, opening a new front in the war against cancer. Two New York Institute of Technology faculty members, assistant professors of life sciences and computer sciences, will combine their skills under a three-year, $568,000 Cutting Edge Basic Research award from the NIH’s National Human Genome Research Institute. Their mission:…


Startup sails past $1M, considers second employee

By GREGORY ZELLER // A key e-commerce alliance has pushed an innovative skin-care company past $1 million in revenues – and has the biotech’s only full-time employee thinking expansion, in more ways than one. Kantian Skincare, a 2012 startup and the public face of Huntington-based Kantian Sciences Corp., hurtled past the $1 million plateau in July, according to cofounder and President Jon Klein, on the back of the Neutralyze Anti-Acne Solution, the company’s flagship product….